The new system will help accelerate the commercialization of Aston Particle Technologies’ dry particle coating technology.
Automation consultancy Innomech has developed a pilot-scale production system for Aston Particle Technologies (APT) that will help the company accelerate the commercialization of its innovative dry particle coating technology. The one-step particle engineering technology by APT enables challenging APIs to be dry powder coated onto carrier particles without the need for heat and solvents. The technology can be applied in the development of dry powder inhaler formulations, solubility enhancement of poorly soluble drugs, and taste-masking of bitter-tasting drugs.
The new easy-to-use system, designed by Innomech, can process up to two kilograms of pharmaceutical powders-a 100-fold increase on the capacity of APT’s existing lab-scale equipment. The system provides a fluidized environment for particle contact and adsorption of cohesive material over coarse particles without the need for heat and solvents. It has pressure and temperature sensors, and an ultra-efficient heat exchanger for monitoring and maintaining the required process conditions.
A touchscreen integrated with a recipe-based control system allows operators to key in the required process conditions for specific production batches. Surfaces and gas flow paths that come into contact with pharmaceutical powders have been kept to a minimum for easy cleaning and maintenance. A high efficiency particulate air (HEPA) filtration system ensures operator safety.
APT is a spin-out from The School of Pharmacy at Aston University. It was founded in 2016 with seed investment and a major Innovate United Kingdom grant.
Source: Innomech
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.